Details for New Drug Application (NDA): 220711
The generic ingredient in BEQALZI is sonrotoclax. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the sonrotoclax profile page.
Summary for 220711
| Tradename: | BEQALZI |
| Applicant: | Beone Medicines Usa |
| Ingredient: | sonrotoclax |
| Patents: | 1 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 220711
Generic Entry Date for 220711*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Suppliers and Packaging for NDA: 220711
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BEQALZI | sonrotoclax | TABLET;ORAL | 220711 | NDA | BeOne Medicines USA, Inc. | 72579-015 | 72579-015-04 | 1 KIT in 1 KIT (72579-015-04) * 11 TABLET, FILM COATED in 1 BLISTER PACK (72579-017-04) * 11 TABLET, FILM COATED in 1 BLISTER PACK (72579-025-04) * 11 TABLET, FILM COATED in 1 BLISTER PACK (72579-022-04) * 11 TABLET, FILM COATED in 1 BLISTER PACK (72579-020-04) |
| BEQALZI | sonrotoclax | TABLET;ORAL | 220711 | NDA | BeOne Medicines USA, Inc. | 72579-017 | 72579-017-01 | 1 BLISTER PACK in 1 CARTON (72579-017-01) / 11 TABLET, FILM COATED in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | May 13, 2026 | TE: | RLD: | Yes | |||||
| Regulatory Exclusivity Expiration: | May 13, 2031 | ||||||||
| Regulatory Exclusivity Use: | NEW CHEMICAL ENTITY | ||||||||
| Patent: | 11,420,968 | Patent Expiration: | Apr 29, 2039 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | May 13, 2026 | TE: | RLD: | Yes | |||||
| Regulatory Exclusivity Expiration: | May 13, 2031 | ||||||||
| Regulatory Exclusivity Use: | NEW CHEMICAL ENTITY | ||||||||
Complete Access Available with Subscription
